Additional file 2: Tables S1a-d. of 
                     TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Munch-Petersen, Helga; Asmar, Fazila; Dimopoulos, Konstantinos; Areškevičiūtė, Aušrinė; Brown, Peter; Girkov, Mia; Pedersen, Anja; Sjö, Lene; Heegaard, Steffen; Broholm, Helle; Kristensen, Lasse; Ralfkiaer, Elisabeth; Grønbæk, Kirsten

doi:10.6084/m9.figshare.c.3595559_D1.v1

40478_2016_307_MOESM2_ESM.pdf (534.59 kB)

Additional file 2: Tables S1a-d. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

journal contribution

posted on 2016-04-22, 05:00 authored by Helga Munch-Petersen, Fazila Asmar, Konstantinos Dimopoulos, Aušrinė Areškevičiūtė, Peter Brown, Mia Girkov, Anja Pedersen, Lene Sjö, Steffen Heegaard, Helle Broholm, Lasse Kristensen, Elisabeth Ralfkiaer, Kirsten Grønbæk

Clinical data in 107 PCNSL patients and TP53, MIR34A, and DAPK subgroups. Tables S2a-b. Disease status (a), and treatment at relapse/progression (b). Tables S3a-d. Immunohistochemical marker expression in 107 PCNSL patients and TP53, MIR34A, and DAPK subgroups. (PDF 534 kb)

Funding

Rigshospitalet Forskningspuljer (DK)

History

Usage metrics

Keywords

PCNSL TP53 MIR34A Hotspot mutations DNA methylation Survival

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC